Mesothelioma Cancer Centers
The University of Kansas Cancer Center – Missouri is part of the larger University of Kansas network, which includes medical schools and various treatment facilities. Included in the network are a children's hospital and institute for medical research, among others.
Cancer care offered within The University of Kansas Cancer Center – Missouri includes state of the art treatment focused on team-based care. The doctors and researchers employed by the center collaborate on how to best use new and standard therapies to treat a patient's specific cancer case. New therapies in use across the center include immune therapy and CAR T-cell therapy.
The cancer center earned NCI-designation, representing their exellence in the field of cancer reaserch. With this designation patients can rest assured that they have the most cutting-edge critical trials and experimental treatments at their disposal. The use of these therapies may lead to extended life expectancies for patients, including those with mesothelioma cancer.
Not only are patients treated by the highly skilled teams within The University of Kansas Cancer Center - Missouri, and the eight other facilities within the system, but all the knowledge gained and currently in use at the centers is shared within The Midwest Cancer Alliance. As a member of the region-wide network, The University of Kansas Cancer Center – Missouri is able to impact patients across the states of Kansas and Missouri.
- Biological therapy
- CAR T-cell treatment
- Clinical trials
- Genetic testing
- Heated intraperitoneal therapy
- High-dose rate brachytherapy
- Hormonal therapy
- Immune therapy
- Interventional oncology
- Palliative care
- Radiation therapy
- National Cancer Institute Designated Cancer Center
- U.S. News & World Report Best Hospitals